JANESVILLE, Wis., May 26, 2022 – SHINE Technologies, LLC (SHINE), a next-generation nuclear technology company, today announced CEO and founder Greg Piefer will give an invited presentation at the Wisconsin Entrepreneurs’ Conference in Milwaukee. On Thursday, June 2 at 8:45 a.m., Piefer will present the opening keynote before engaging in discussion with the audience.  

Produced by the Wisconsin Technology Council, the Entrepreneurs’ Conference is among the largest events for entrepreneurs and early-stage investors in the Upper Midwest. The theme for the 20th annual conference is “Putting Early Stage Pieces Together.” It is one of the Midwest’s premiere hands-on events for entrepreneurs of all ages and experience levels. Attendees range from entrepreneurs who are still developing their ideas to emerging company leaders who have already attracted angel and/or venture funding. These businesses cover a broad span of categories, from information technology to cleantech, from advanced manufacturing to the life sciences, and from business services to consulting. 

Piefer will discuss progress at SHINE, headquartered in Janesville, Wis., which raised several hundred million dollars from investors in the last three years alone for its revolutionary, fusion-based technologies. Early applications include production of commonly used medical radioisotopes to diagnose and treat serious illnesses such as heart disease and cancer.  

Piefer holds a Ph.D. in nuclear engineering and related degrees from UW-Madison. A recent speaker at a White House summit on commercial fusion energy, Piefer has received the UW-Madison Early Career award; is the primary inventor on multiple patents; is author or co-author of many publications; and serves on several for-profit and non-profit board of directors. 

Registration is open at witrepsconference.com 

SHINE is a next-generation nuclear technology company, deploying state-of-the-art fusion technology to create a scalable path toward fusion energy. Based in southern Wisconsin, with headquarters in Janesville, and with a future site in development in Europe, SHINE deploys its safe, cost-effective and environmentally friendly technology in a step-wise approach. Our systems are used for industrial imaging of components in aerospace, defense, transportation, energy and other sectors. And SHINE’s proprietary isotope production processes create molybdenum-99 and non-carrier-added lutetium-177 used in tens of thousands of daily procedures to diagnose and treat heart disease and late-stage cancer. For more information, follow SHINE on FacebookLinkedIn and Twitter.

SHINE Technologies
Patrick O’Connell
VP, Marketing & Communications